[LGND] YoY Quarter Result on 31-Mar-2009 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
11-May-2009
Financial Year
2009
Quarter
31-Mar-2009 [#Q1]
Profit Trend
QoQ- 92.65%
YoY- -30.08%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Revenue 5,636 3,896 5,958 9,470 4,874 235 50,956 -30.69%
PBT -522 -4,292 -2,715 -7,482 -11,498 -26,083 -142,212 -60.69%
Tax -35 -13,778 274 -2,366 -1,781 -9,194 17 -
NP 1,133 9,625 -2,750 -5,116 -3,933 274,321 -142,229 -
Tax Rate - - - - - - - -
Total Cost 4,503 -5,729 8,708 14,586 8,807 -274,086 193,185 -46.52%
Ratio Analysis
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
NP Margin 20.10 247.05 -46.16 -54.02 -80.69 116,732.34 -279.12 -
Per Share
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
EPS 0.07 0.49 -0.14 -0.27 -0.25 16.32 -11.01 -
EPS Diluted 0.07 0.49 -0.14 -0.27 -0.25 16.32 -11.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.